testing guidelines

News
Genetic Testing Underutilized in Women With History of Ovarian Cancer
08/22/2017
JCP Editors
Less than 20% of patients with a history of ovarian cancer meeting National Comprehensive Cancer Network (NCCN) guidelines have undergone genetic testing or have discussed testing with their health care...
Less than 20% of patients with a history of ovarian cancer meeting National Comprehensive Cancer Network (NCCN) guidelines have undergone genetic testing or have discussed testing with their health care...
Less...
08/22/2017
Journal of Clinical Pathways
Research in Review
Novel Ovarian Cancer Subtypes Associated With Survival Outcomes Following Surgery
08/02/2017
JCP Editors
High-grade serous ovarian cancer can be categorized in five molecular subtypes associated with survival and surgical outcomes, according to research published in Clinical Cancer Research (August...
High-grade serous ovarian cancer can be categorized in five molecular subtypes associated with survival and surgical outcomes, according to research published in Clinical Cancer Research (August...
...
08/02/2017
Journal of Clinical Pathways
Research in Review
Comparing Prognostic Values of MRI or PET-CT at Multiple Myeloma Diagnosis
07/12/2017
JCP Editors
Researchers identified which imaging technique is better for evaluating prognosis of newly-diagnosed multiple myeloma, published in the Journal of Clinical Oncology (published online July 7, 2017;...
Researchers identified which imaging technique is better for evaluating prognosis of newly-diagnosed multiple myeloma, published in the Journal of Clinical Oncology (published online July 7, 2017;...
...
07/12/2017
Journal of Clinical Pathways
Research in Review
Prostate Cancer Scanning Helps Detect Further Disease, Improve Care
06/28/2017
JCP Editors
Positron emission tomography (PET) and computed tomography (CT) scans specific to prostate cancer can detect further disease and improve clinical management, according to recent research. Ga68-Prostate Specific...
Positron emission tomography (PET) and computed tomography (CT) scans specific to prostate cancer can detect further disease and improve clinical management, according to recent research. Ga68-Prostate Specific...
...
06/28/2017
Journal of Clinical Pathways
Research in Review
Underused Blood Test Helps Alter Treatment Strategy for Colon Cancer
06/26/2017
JCP Editors
A routinely available blood test can help improve risk stratification and guide additional therapy for stage II colon cancer. ----- Related Content Adjuvant Chemotherapy Improves Colon Cancer Outcomes Colon...
A routinely available blood test can help improve risk stratification and guide additional therapy for stage II colon cancer. ----- Related Content Adjuvant Chemotherapy Improves Colon Cancer Outcomes Colon...
A...
06/26/2017
Journal of Clinical Pathways
Research in Review
Prostate Cancer Testing Guidelines Omit Critical Genetic Features
06/13/2017
JCP Editors
Current National Comprehensive Cancer Network (NCCN) guidelines and Gleason scores cannot reliably stratify patients with risk of prostate cancer for the presence or absence of pathogenic germline variants,...
Current National Comprehensive Cancer Network (NCCN) guidelines and Gleason scores cannot reliably stratify patients with risk of prostate cancer for the presence or absence of pathogenic germline variants,...
...
06/13/2017
Journal of Clinical Pathways
Research in Review
Early PET Scan Improves Outcomes for Patients With Hodgkin Lymphoma
06/08/2017
JCP Editors
Response to positron emission tomography (PET) scan after two cycles of standard treatment allows for early treatment adaption for patients with early-stage Hodgkin lymphoma, according to research published in the...
Response to positron emission tomography (PET) scan after two cycles of standard treatment allows for early treatment adaption for patients with early-stage Hodgkin lymphoma, according to research published in the...
...
06/08/2017
Journal of Clinical Pathways
Research in Review
Financial Burden for Patients With Early-Stage Breast Cancer After Surveillance Testing
05/31/2017
JCP Editors
Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...
Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...
Women...
05/31/2017
Journal of Clinical Pathways
Research in Review
PARP-1 Measurement Guides Treatment Decisions in Ovarian Cancer
05/12/2017
JCP Editors
New research shows that blocking poly (ADP-ribose) polymerase-1 (PARP-1) may have a greater impact than restoring BRCA1 for the treatment of ovarian cancer, according to research presented at the 2017 American...
New research shows that blocking poly (ADP-ribose) polymerase-1 (PARP-1) may have a greater impact than restoring BRCA1 for the treatment of ovarian cancer, according to research presented at the 2017 American...
New...
05/12/2017
Journal of Clinical Pathways
Department
Researchers Offer Protocol for Cardiac Monitoring in Cancer Survivors
03/15/2017
JCP Editors
Researchers debuted guidelines for a two-tiered cardiac monitoring system aimed at identifying cancer survivors considered at high risk for cardiotoxic events. ----- Related Content Prostate Cancer Treatment...
Researchers debuted guidelines for a two-tiered cardiac monitoring system aimed at identifying cancer survivors considered at high risk for cardiotoxic events. ----- Related Content Prostate Cancer Treatment...
...
03/15/2017
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use